Search results
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 7 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 6 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Expert's five 'surprising' early signs of dementia you could easily miss
Daily Express· 7 days agoWhile these symptoms should prompt a visit to the doctor, Dr Rankin says it’s important to note they...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 6 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 7 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Melanoma skin cancer vaccine being trialled on NHS halves risk of death or relapse
Daily Telegraph· 6 days agoMeanwhile, another study by the Danish biotech firm Evaxion and the Melanoma Institute Australia at...
'Exciting' skin cancer vaccine halves risk of relapse or death in study
Daily Express· 6 days agoA cutting-edge skin cancer vaccine being trialled on NHS patients halves the risk of death or...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 7 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
TuHURA reports breakthrough in cancer vaccine trial By Investing.com
Investing.com· 7 days agoTuHURA Biosciences, Inc., in collaboration with Kintara Therapeutics, Inc. (NASDAQ:KTRA), has...
NHS England launches pioneering trials for world-first cancer vaccine
BioPharma-Reporter· 7 days agoTo date, thirty hospitals have joined NHS England's Cancer Vaccine Launch Pad, which aims to...